White Knight Strategic Wealth Advisors’s Pfizer PFE Stock Holding History

White Knight Strategic Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$548K	Sell	19,515 -5,521	-22%	-$147K	0.46%	48
2025 Q4	$623K	Buy	25,036 +10,174	+68%	+$257K	0.46%	50
2025 Q3	$379K	Buy	14,862 +485	+3%	+$12K	0.3%	58
2025 Q2	$348K	Buy	14,377 +4,980	+53%	+$116K	0.3%	61
2025 Q1	$238K	Sell	9,397 -13,757	-59%	-$360K	0.22%	74
2024 Q4	$614K	Buy	23,154 +7,772	+51%	+$211K	0.26%	63
2024 Q3	$445K	Hold	15,382	–	–	0.4%	50
2024 Q2	$430K	Buy	15,382 +1,902	+14%	+$52.4K	0.43%	44
2024 Q1	$374K	Buy	13,480 +4	+0%	+$111	0.39%	50
2023 Q4	$388K	Sell	13,476 -7,052	-34%	-$213K	0.45%	46
2023 Q3	$681K	Buy	20,528 +604	+3%	+$21.4K	0.9%	26
2023 Q2	$731K	Buy	19,924 +2,781	+16%	+$108K	0.86%	28
2023 Q1	$699K	Buy	17,143 +4,385	+34%	+$189K	0.88%	28
2022 Q4	$654K	Sell	12,758 -488	-4%	-$23.4K	0.9%	30
2022 Q3	$580K	Buy	+13,246	New	+$644K	0.83%	31

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

White Knight Strategic Wealth Advisors's PFE Position: Q1 2026 in Review

White Knight Strategic Wealth Advisors reduced its Pfizer (PFE) stake by 22% in Q1 2026, selling an estimated $147K and leaving 19,515 shares worth $548K. The position accounts for 0.46% of the portfolio, ranked #48.

White Knight Strategic Wealth Advisors first reported a position in PFE in Q3 2022 and has held it in 15 quarters since. The position peaked at $731K in Q2 2023. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

White Knight Strategic Wealth Advisors held 19,515 shares of Pfizer worth $548K as of Q1 2026.
White Knight Strategic Wealth Advisors sold 5,521 Pfizer shares in Q1 2026, an estimated $147K.
Pfizer made up 0.46% of White Knight Strategic Wealth Advisors's portfolio in Q1 2026, its #48 holding.
White Knight Strategic Wealth Advisors first reported a position in Pfizer in Q3 2022 and has held it in 15 quarters since.
White Knight Strategic Wealth Advisors's Pfizer position peaked at $731K in Q2 2023.
2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on White Knight Strategic Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.